Conversion Surgery for Initially Unresectable, Locally Advanced, Metastatic or Recurrent Gastrointestinal Cancers

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".

Deadline for manuscript submissions: 31 January 2026 | Viewed by 33

Special Issue Editor


E-Mail Website
Guest Editor
Department of Surgery, Yokohama Medical Center, Yokohama 236-0004, Japan
Interests: gastrointestinal cancer

Special Issue Information

Dear Colleagues,

In recent years, remarkable advances in chemotherapy, radiotherapy, molecular targeted therapy, and particularly immunotherapy have made it possible to achieve long-term tumor control even in gastrointestinal cancers with locally advanced disease or distant metastases. As a result, the efficacy of conversion surgery in patients who have responded favorably to such treatments is being increasingly reported. Notably, in selected cases of distant metastasis—so-called oligometastases—curative treatment may be achievable.

This Special Issue aims to explore the role of conversion surgery for malignant tumors in the gastrointestinal and hepatobiliary-pancreatic regions. We warmly invite submissions that discuss the characteristics of patients eligible for conversion surgery, treatment outcomes according to prior therapies, and both short- and long-term postoperative results in order to clarify the clinical value of this approach.

Through this initiative, we hope to contribute to the advancement of multidisciplinary treatment strategies and to offer new curative options for patients who were once considered untreatable.

This Special Issue welcomes original research articles, review articles, and translational research papers. The central theme is conversion surgery with curative intent following chemotherapy, molecular targeted therapy, and/or radiotherapy for gastrointestinal cancers, including those that are locally advanced, metastatic (e.g., oligometastatic), or recurrent. The primary cancer types of interest include esophageal cancer, gastric cancer, malignant tumors of the small intestine, colorectal cancer, pancreatic cancer, biliary tract cancer, and primary liver cancer.

We look forward to receiving your valuable contributions.

Dr. Takashi Murakami
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • conversion surgery
  • locally advanced disease
  • metastatic disease
  • chemotherapy
  • radiotherapy
  • immunotherapy
  • heptobiliary-pancreatic cancers
  • gastrointestinal tract cancers

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop